Related Experiment Video

Updated: Apr 30, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

13.6K

Emerging therapies for refractory chronic lymphocytic leukemia

Nadine Kutsch1, Michael Hallek, Barbara Eichhorst

  • 1Department I of Internal Medicine, Center of Integrated Oncology (CIO), CECAD (Cluster of Excellence in Cellular Stress Responses in Aging-associated Diseases) and German CLL Study Group (DCLLSG), University of Cologne , Cologne , Germany.

Leukemia & Lymphoma
|April 29, 2014
PubMed

Insights

Novel therapies offer new hope for chemotherapy-refractory Chronic Lymphocytic Leukemia (CLL) patients with poor prognoses. Emerging treatments may soon replace traditional stem cell transplants for relapsed, refractory CLL.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Chemotherapy-refractory Chronic Lymphocytic Leukemia (CLL) presents a significant clinical challenge with poor patient outcomes.
  • Current treatment options for relapsed, refractory CLL are limited, with allogeneic stem cell transplant being the sole curative approach.

Purpose of the Study:

  • To review current data on novel therapeutic agents for chemotherapy-refractory CLL.
  • To provide an outlook on future treatment strategies for this patient population.

Main Methods:

  • Literature review of clinical development data for novel CLL therapies.
  • Analysis of emerging treatment modalities including small molecules, antibodies, and cellular therapies.

Main Results:

  • Several novel agents, including kinase inhibitors, BCL-2 antagonists, and CAR-T cells, show promise with high efficacy and favorable safety profiles.
  • These new substances are being developed for patients with relapsed, refractory CLL.

Conclusions:

  • Novel therapeutic agents are emerging as promising alternatives for chemotherapy-refractory CLL.
  • These advancements may potentially supersede allogeneic stem cell transplant as a curative option in the future.
Keywords:
BCL-2 antagonistsCARTsRefractory/relapsed CLLimmunomodulatorskinase inhibitorsnew antibodiessmall molecules

More Related Videos

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.0K
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

23.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K